BLOG

Saturday, November 7, 2020

Biocon Biologics gets capital injection of Rs $150 mn from Goldman Sachs

Transaction values the IPO-bound biologics arm of Biocon at $3.94 billion

from Companies https://ift.tt/3mUUmxY
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...